A COVID-19 vaccine manufactured by the British-Swedish firm AstraZeneca appears to provide strong protection three months after just one dose while also curbing spread of infections, researchers said Wednesday.
British Health Secretary Matt Hancock said the study supports a strategy of delaying the second shot so more first doses can be delivered to more people. Researchers also found a 67% reduction in positive swabs among those vaccinated – crucial news because if no virus is present, the virus can t spread.
AstraZeneca has not yet applied for emergency use authorization for its vaccine in the U.S. Just two vaccines, by Pfizer-BioNTech and by Moderna, have been authorized in the U.S., and both require a second dose.
As more Americans anxiously wait their turn to get the COVID-19 vaccine, people are discovering that smokers are one of the priority groups for vaccination.
Some don’t agree with the guidance and have expressed their frustrations on social media. But health experts say the rationale is clear.
“I could see why people would feel as if that would be unfair but people who are smokers are in general at higher risk for getting sicker when they develop COVID-19,” said Dr. Samuel Kim, a thoracic surgeon at Northwestern Medicine in Chicago.
A study, published Jan. 25 in the peer-reviewed journal JAMA Internal Medicine, found that people who smoke or who have smoked in the past are more likely to be hospitalized or die from COVID-19 than people who haven’t smoked.
US tops 450K deaths as CDC reports downward trajectory in cases; Yankee Stadium to open as mass vaccination site: Latest COVID-19 updates. John Bacon, Elinor Aspegren and Doyle Rice, USA TODAY
Experts including Dr. Fauci say double masking could help prevent COVID-19 spread
Replay Video UP NEXT
A COVID-19 vaccine manufactured by the British-Swedish firm AstraZeneca appears to provide strong protection three months after just one dose while also curbing spread of infections, researchers said Wednesday.
British Health Secretary Matt Hancock said the study supports a strategy of delaying the second shot so more first doses can be delivered to more people. Researchers also found a 67% reduction in positive swabs among those vaccinated – crucial news because if no virus is present, the virus can t spread.
US tops 450K deaths as CDC reports downward trajectory in cases; Yankee Stadium to open as mass vaccination site: Latest COVID-19 updates. John Bacon, Elinor Aspegren and Doyle Rice, USA TODAY
Experts including Dr. Fauci say double masking could help prevent COVID-19 spread
Replay Video UP NEXT
A COVID-19 vaccine manufactured by the British-Swedish firm AstraZeneca appears to provide strong protection three months after just one dose while also curbing spread of infections, researchers said Wednesday.
British Health Secretary Matt Hancock said the study supports a strategy of delaying the second shot so more first doses can be delivered to more people. Researchers also found a 67% reduction in positive swabs among those vaccinated – crucial news because if no virus is present, the virus can t spread.
US tops 450K deaths as CDC reports downward trajectory in cases; Yankee Stadium to open as mass vaccination site: Latest COVID-19 updates. John Bacon, Elinor Aspegren and Doyle Rice, USA TODAY
Experts including Dr. Fauci say double masking could help prevent COVID-19 spread UP NEXT
A COVID-19 vaccine manufactured by the British-Swedish firm AstraZeneca appears to provide strong protection three months after just one dose while also curbing spread of infections, researchers said Wednesday.
British Health Secretary Matt Hancock said the study supports a strategy of delaying the second shot so more first doses can be delivered to more people. Researchers also found a 67% reduction in positive swabs among those vaccinated – crucial news because if no virus is present, the virus can t spread.